Table 5. Rate Ratios for a Diagnosis of Myocarditis within 30 Days after the Second Dose of Vaccine, as Compared with Unvaccinated Persons (January 11 to May 31, 2021).
Age and Sex | Vaccinated Group | Unvaccinated Group | Rate Ratio (95% CI) |
||
---|---|---|---|---|---|
Person-Days of Follow-up | Cases | Person-Days of Follow-up | Cases | ||
number | |||||
All recipients * | 149,786,065 | 117 | 296,377,727 | 98 | 2.35 (1.10–5.02) |
16–19 yr | |||||
Male | 6,018,541 | 31 | 19,135,706 | 11 | 8.96 (4.50–17.83) |
Female | 6,033,192 | 2 | 17,768,696 | 2 | 2.95 (0.42–20.91) |
20–24 yr | |||||
Male | 7,088,335 | 27 | 20,926,320 | 13 | 6.13 (3.16–11.88) |
Female | 6,889,399 | 5 | 20,832,407 | 2 | 7.56 (1.47–38.96) |
25–29 yr | |||||
Male | 6,590,263 | 18 | 20,944,595 | 16 | 3.58 (1.82–7.01) |
Female | 6,417,564 | 1 | 20,943,920 | 0 | 0 |
≥30 yr | |||||
Male | 53,577,403 | 26 | 82,419,957 | 40 | 1.00 (0.61–1.64) |
Female | 57,171,368 | 7 | 93,406,126 | 14 | 0.82 (0.33–2.02) |
Data for all vaccine recipients have been weighted according to age and sex.